PROTEOMICS OF TEAR IN INACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY

被引:0
作者
Jiang, L. [1 ]
Wei, R. [1 ]
Diao, J. [1 ]
Ding, H. [1 ]
Wang, W. [1 ]
Ao, R. [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Ophthalmol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Tear proteomics; Thyroid-associated ophthalmopathy; Inactive stage; Bioinformatics; GRAVES OPHTHALMOPATHY; HORMONE; ORBITOPATHY; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Thyroid-associated ophthalmopathy (TAO), one of the most common orbital diseases in adults, seriously reduces patients' quality of life. Although human tear proteomics identified many abnormal expressed proteins and proposed several pathogeneses of TAO, most of these studies focused on the active stage or mixed types in TAO. In this study we identified significantly changed proteins and preliminary revealed the potential signalling pathways and mechanisms of TAO with the late, inactive stage. Patients and Methods. Tears from TAO patients (n=6) with a CAS score < 3 and 6 control healthy subject were collected. The pooled tears were further fractionated using high pH reversed-phase chromatography, then submitted to LC-MS/MS and subsequent bioinformatic analysis. Results. Proteomic profiling identified 107 significantly changed proteins between the inactive stage of TAO patients and healthy cases. Among these proteins, 62 were upregulated, and 45 were downregulated in TAO cases compared to healthy individuals. Enrichment analysis revealed that the immune system, cell cycle, metabolism (carbohydrate metabolism and metabolism of cofactors and vitamins), protein synthesis and degradation might play a vital role in the progress of inactive TAO. The present investigation represents the first proteomic tear study of TAO patients in the inactive stage. Conclusion. The results shed light on the differences between inactive TAO patients and healthy cases, thus enabling us to understand better the molecular mechanisms and potential targets for the treatment of inactive TAO.
引用
收藏
页数:13
相关论文
共 28 条
[1]   Comparative proteomic analysis of tear fluid in Graves' disease with and without orbitopathy [J].
Aass, C. ;
Norheim, I. ;
Eriksen, E. F. ;
Bornick, E. C. ;
Thorsby, P. M. ;
Pepaj, M. .
CLINICAL ENDOCRINOLOGY, 2016, 85 (05) :805-812
[2]   T-cell-mediated immunity in thyroid-associated ophthalmopathy [J].
Bednarczuk, T ;
Hiromatsu, Y ;
Inoue, Y ;
Yamamoto, K ;
Wall, JR ;
Nauman, J .
THYROID, 2002, 12 (03) :209-215
[3]   Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score [J].
Choi, Won ;
Li, Ying ;
Ji, Yong Sok ;
Yoon, Kyung Chul .
BMC OPHTHALMOLOGY, 2018, 18
[4]   Pathogenesis of Graves ophthalmopathy: Implications for prediction, prevention, and treatment [J].
Garrity, James A. ;
Bahn, Rebecca S. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :147-153
[5]   Flippases and vesicle-mediated protein transport [J].
Graham, TR .
TRENDS IN CELL BIOLOGY, 2004, 14 (12) :670-677
[6]   Tear film analysis and evaluation of optical quality: A review of the literature [J].
Herbaut, A. ;
Liang, H. ;
Denoyer, A. ;
Baudouin, C. ;
Labbe, A. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2019, 42 (02) :E21-E35
[7]   The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor [J].
Hollenberg, Anthony N. .
THYROID, 2008, 18 (02) :131-139
[8]   Analysis of Graves' ophthalmopathy patients' tear protein spectrum [J].
Jiang Li-hong ;
Wei Rui-li .
CHINESE MEDICAL JOURNAL, 2013, 126 (23) :4493-4498
[9]   Tear proteomics of orbital decompression for disfiguring exophthalmos in inactive thyroid-associated ophthalmopathy [J].
Jiang, Lihong ;
Rong, Ao ;
Wei, Ruili ;
Diao, Jiale ;
Ding, Hui ;
Wang, Wei .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (06)
[10]   Is modified clinical activity score an accurate indicator of diplopia progression in Graves' orbitopathy patients? [J].
Kim, Ji Won ;
Woo, Young Jun ;
Yoon, Jin Sook .
ENDOCRINE JOURNAL, 2016, 63 (12) :1133-1140